SCHEMBL9516723

SCHEMBL9516723

NC(N)C1([Pt+2])CCCCC1.NC(N)C1([Pt+2])CCCCC1.O=C([O-])C(CCOCCOCCOCCOCCC(C(=O)[O-])C(=O)[O-])C(=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9518718 0.69
SCHEMBL9517588 0.69 THRB (0.33)
Ethylenediamine SCHEMBL9516578 0.66 MEN1 (0.41)
SCHEMBL9517478 0.63
SCHEMBL9516487 0.63
SCHEMBL9516593 0.58 NOS3 (0.38)
SCHEMBL7013695 0.56 TSHR (0.37)
SCHEMBL15710640 0.53 GABRR1 (0.39)
Aspartic Acid SCHEMBL8406706 0.52 CA4 (0.42)
Aspartic Acid SCHEMBL8406708 0.52 CA4 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0341409-B1 Platinum (II) complexes, their preparation and use as antitumour agents BOEHRINGER MANNHEIM ITALIA (IT) 1993-12-29 EP disclosed